Spanish BMT4me Usability & Acceptability
Recruiting
The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.
Gender:
ALL
Ages:
Between 0 years and 17 years
Trial Updated:
02/10/2025
Locations: Columbia University Irving Medical Center, New York, New York +1 locations
Conditions: Bone Marrow Transplant
WiTNNess - TNNT1 Myopathy Natural History Study
Recruiting
WiTNNess is designed to accurately document the natural course and variation of muscle disease caused by pathogenic changes of the TNNT1 gene. The primary aim of the study is to specify meaningful outcome measures for future clinical trials. WiTNNess is open to children and adults worldwide. Participants can choose to include their information once (cross-sectional cohort) or every few months (prospective cohort).
Gender:
ALL
Ages:
All
Trial Updated:
02/10/2025
Locations: Clinic for Special Children, Gordonville, Pennsylvania
Conditions: TNNT1-associated Myopathy, Infantile-onset Nemaline Rod Myopathy, Myopathies, Nemaline, Myopathy, Myopathy, Rod, Myopathy; Hereditary, Amish Nemaline Myopathy, Nemaline Myopathy 5, NEM5, Genetic Muscle Disease, Recessive Hereditary Disorder (Autosomal), ANM
Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
Recruiting
The goal of this clinical trial is to assess the safety, toxicity, and antitumor activity of fourth ventricular infusions of nivolumab plus 5-azacytidine for recurrent ependymoma and nivolumab plus methotrexate for recurrent medulloblastoma and other CNS malignancies. Additionally, the study will explore immunologic responses to nivolumab. The hypothesis is that local administration of nivolumab, an immune checkpoint inhibitor, is safe and will lead to even more robust treatment responses when... Read More
Gender:
ALL
Ages:
Between 1 year and 80 years
Trial Updated:
02/10/2025
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Recurrent Ependymoma, Recurrent Medulloblastoma, CNS Malignancies
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
Recruiting
B cell-depleting therapies, such as ocrelizumab, are among the most effective medications currently available for the treatment of multiple sclerosis (MS). This suggests that B cells play a very important role in MS. While B cells are rapidly eliminated from the blood of patients treated with medications like ocrelizumab, little is known about how effectively B cells are eliminated from lymph nodes, which are important sites of B cell activation. This study is being conducted to determine to wha... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
02/10/2025
Locations: University of California, San Francisco, San Francisco, California
Conditions: Multiple Sclerosis, Relapsing-Remitting
Adaptive Rock Climbing
Recruiting
The goal of this clinical trial is to assess changes in functional and psychosocial outcomes following a 12-week adaptive rock-climbing program for children with congenital upper limb differences. The main questions it aims to answer are * Assess functional outcomes following a 12-week adaptive rock-climbing program. * Assess psychosocial outcomes following a 12-week adaptive rock climbing program. * Assess barriers to participation in adaptive sports. Participants will complete 12-week adapti... Read More
Gender:
ALL
Ages:
Between 6 years and 16 years
Trial Updated:
02/10/2025
Locations: Children Hospital Los Angeles, Los Angeles, California
Conditions: Congenital Upper Limb Differences
Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
Recruiting
This is a Phase Ib/II, open-label, single institution dose-escalation, safety, pharmacokinetics, pharmacodynamic and efficacy study.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/10/2025
Locations: University of Texas Health Science Center at San Antonio, San Antonio, Texas
Conditions: Advanced Lung Adenocarcinoma
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
Recruiting
This clinical trial will examine the effects of legal services on primary care outcomes for medically underserved communities. The aims of the study are: 1. To test the effectiveness and cost-benefits of a critical-time intervention Medical-Legal Partnership (CTI-MLP) on patient outcomes. 2. To determine the most efficient mechanisms for CTI-MLP delivery. 3. To develop innovative community engagement strategies for addressing health-harming legal needs within community health centers. Eligibl... Read More
Gender:
ALL
Ages:
13 years and above
Trial Updated:
02/10/2025
Locations: Betances Health Center, New York, New York
Conditions: Health Harming Legal Needs
Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis
Recruiting
This is a prospective clinical trial intended to capture echocardiographic images in patients clinically indicated for an echocardiographic examination using an additional Point of Care Ultrasound device . The images collected will be used to test and possibly validation an AI base Aortic Valve Stenosis algorithm
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/10/2025
Locations: Northwestern University, Chicago, Illinois
Conditions: Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease
Short Course Radiation Treatment for Patients with Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery
Recruiting
To determine the safety of moderately hypofractionated radiation in the treatment of primary and locally recurrent RPS, based on the evaluation of acute radiation-related toxicity profile of each participant (30-day radiation toxicity)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/10/2025
Locations: Brigham and Women's Hospital / Dana Farber Cancer Institute, Boston, Massachusetts
Conditions: Retroperitoneal Sarcoma
Validation of Nanosensor Oxygen Measurement
Recruiting
Past mitochondrial disease treatment studies have been unsuccessful in determining treatment efficacy, and a major factor has been the lack of validated biomarkers in mitochondrial myopathy (MM). There is currently a growing number of potential new treatments to be tested through MM clinical intervention trials, which has created a pressing need for quantitative biomarkers that reliably reflect MM disease severity, progression, and therapeutic response. The purpose of the study is to measure the... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
02/10/2025
Locations: The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Conditions: MItochondrial Myopathies, Mitochondrial Disease
Wireless Prosthetic Control Effectiveness Study
Recruiting
The goal of this proposed project is to evaluate the effectiveness of our novel wireless electrode system, which the investigators refer to as the ASTERISK system, on transradial prosthesis users. There are numerous benefits to the upper limb prosthesis community being able to utilize wireless electrodes. These benefits include allowing for the use of a prosthetics liner to assist with fit and comfort, easier implementation of EMG-controlled prosthesis for individuals with osseointegration, and... Read More
Gender:
ALL
Ages:
Between 18 years and 89 years
Trial Updated:
02/10/2025
Locations: Liberating Technologies, Inc., Holliston, Massachusetts
Conditions: Prostheses, Upper Limb Amputation Below Elbow
Emergency Preservation and Resuscitation (EPR) for Cardiac Arrest From Trauma
Recruiting
The goal of this study is to rapidly cool trauma victims who have suffered cardiac arrest from bleeding with a flush of ice-cold sodium chloride to preserve the patient to enable surgical control of bleeding, followed by delayed resuscitation with cardiopulmonary bypass.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
02/09/2025
Locations: University of Maryland, Baltimore, Maryland
Conditions: Cardiac Arrest From Trauma